Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial results for Quarter ended December 31, 2024.